Legal & General Group’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-30,901
| Closed | -$1.22M | – | 3562 |
|
|
2024
Q1 | $1.22M | Buy |
30,901
+4,638
| +18% | +$184K | ﹤0.01% | 2128 |
|
|
2023
Q4 | $501K | Buy |
26,263
+3,548
| +16% | +$67.6K | ﹤0.01% | 2447 |
|
|
2023
Q3 | $260K | Buy |
22,715
+19,223
| +550% | +$220K | ﹤0.01% | 2656 |
|
|
2023
Q2 | $35.9K | Buy |
3,492
+1,019
| +41% | +$10.5K | ﹤0.01% | 2918 |
|
|
2023
Q1 | $19.1K | Hold |
2,473
| – | – | ﹤0.01% | 3078 |
|
|
2022
Q4 | $18.2K | Buy |
2,473
+1,031
| +71% | +$7.57K | ﹤0.01% | 3177 |
|
|
2022
Q3 | $10K | Hold |
1,442
| – | – | ﹤0.01% | 3344 |
|
|
2022
Q2 | $12K | Buy |
1,442
+215
| +18% | +$1.79K | ﹤0.01% | 3356 |
|
|
2022
Q1 | $11K | Hold |
1,227
| – | – | ﹤0.01% | 3389 |
|
|
2021
Q4 | $17K | Hold |
1,227
| – | – | ﹤0.01% | 3337 |
|
|
2021
Q3 | $13K | Hold |
1,227
| – | – | ﹤0.01% | 3405 |
|
|
2021
Q2 | $11K | Buy |
+1,227
| New | +$11K | ﹤0.01% | 3414 |
|